What is Medikabazaar?
Medikabazaar, operated by Boston Ivy Healthcare Solutions Pvt. Ltd., functions as India's premier online marketplace for medical products and supplies. By bridging the gap between manufacturers and healthcare establishments, the platform offers a comprehensive ecosystem that includes product procurement, consultation, and post-sales support. The company serves a diverse clientele, ranging from small clinics to large-scale hospitals, ensuring that medical facilities have reliable access to critical inventory. Through its technology-driven approach, Medikabazaar has effectively transformed the fragmented medical supply landscape into a cohesive, efficient digital marketplace, positioning itself as a vital infrastructure provider for the healthcare industry.
How much funding has Medikabazaar raised?
Medikabazaar has raised a total of $445M across 4 funding rounds:
Series A
$5M
Series B
$300M
Series C
$75M
Other Financing Round
$65M
Series A (2018): $5M with participation from KOIS and HealthQuad
Series B (2020): $300M led by Ackermans & Van Haaren
Series C (2021): $75M supported by Sumitomo Mitsui Financial Group, CDC Group, Ackermans & Van Haaren, and KOIS
Other Financing Round (2022): $65M featuring Creaegis, KOIS Holdings, British International Investment, Ackermans & Van Haaren, HealthQuad, and Lighthouse India Fund
Key Investors in Medikabazaar
Ackermans & Van Haaren
A Belgian holding company established in 1876, specializing in diverse sectors including marine engineering, private banking, and growth capital investments.
HealthQuad
India's leading healthcare innovation fund that provides both financial capital and clinical strategic guidance to transform healthcare delivery models.
KOIS
A private equity investor focused on blended finance instruments to scale sustainable solutions in healthcare, education, and climate sectors.
What's next for Medikabazaar?
With the recent capital injection, Medikabazaar is well-positioned to scale its logistics infrastructure and enhance its digital procurement platform. The company is expected to focus on deepening its penetration in tier-2 and tier-3 cities, where the demand for standardized medical supplies remains high. Furthermore, the strategic backing from global institutional investors suggests a potential move toward broader international market integration and the expansion of its service portfolio to include advanced healthcare technology solutions. As the firm matures, its focus will likely shift toward optimizing supply chain resilience and leveraging data analytics to predict demand, thereby cementing its role as an indispensable partner in the global healthcare value chain.
See full Medikabazaar company page
